RDY: Analysis & Opinions

  1. Beam's North American Business Beams Brightly

    May 06, 2013
    Beam (NYSE:BEAM) announced solid first quarter earnings May 2. The highlight of Q1 was the performance of its North ...
  2. Dr. Reddy's Misses on Both Counts - Analyst Blog

    February 15, 2013
    Dr. Reddy's Laboratories (RDY) reported third quarter fiscal 2013 earnings per American Depositary Share (ADS) of 40 ...
  3. Eli Lilly Beats Expectations - Analyst Blog

    January 29, 2013
    Eli Lilly & Company (LLY) reported fourth quarter 2012 adjusted earnings per share of 85 cents, well above the Zacks ...
  4. Generic Launch at Dr. Reddy's - Analyst Blog

    January 28, 2013
    Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Merck & Co's (MRK) Singulair ...
  5. Dr. Reddy's Launches Generic Propecia - Analyst Blog

    January 07, 2013
    Dr. Reddy's Laboratories Ltd. (RDY) recently announced that it has launched its generic version of Merck & Co., ...
  6. Another Generic Launch at Mylan - Analyst Blog

    December 31, 2012
    Mylan Inc. (MYL) recently announced that it has launched its generic version of Teva's (TEVA) Nordette 28 Tablets ...
  7. Good News for Mylan - Analyst Blog

    December 21, 2012
    Mylan Inc. (MYL) recently entered into a settlement agreement with Orion Corporation to resolve the patent ...
  8. Rumors About A Diageo-Beam Tie-Up Are Interesting, But ...

    December 12, 2012
    Rumors about Diageo and Beam are more amusing than probable.
  9. Brown-Forman May Struggle To Keep This Premium

    December 07, 2012
    Brown-Forman seems overpriced relative to its real growth potential.
  10. Regeneron Pharmaceuticals Among Healthcare's Biggest ...

    November 30, 2012
    This morning's trading has marked a bad day for the market so far. The Nasdaq has decreased 0.4%; the S&P 500 has ...
  11. The Liquor Business Scores In The BRIC

    November 23, 2012
    Businessweek ran an article Nov. 21 on BEAM's moves in the Russian market. The liquor business looks to score big in ...
  12. Another Generic from Dr. Reddy's - Analyst Blog

    November 23, 2012
    Dr. Reddy's Laboratories (RDY) recently launched its generic version of Pfizer's (PFE) pulmonary arterial ...
  13. Pfizer Misses on Revs, Narrows View - Analyst Blog

    November 01, 2012
    Pfizer Inc. (PFE) posted third quarter earnings of 53 cents per share, a penny above the Zacks Consensus Estimate ...
  14. Solid Quarter at Dr. Reddy's - Analyst Blog

    October 31, 2012
    Dr. Reddy's Laboratories (RDY) reported second quarter fiscal 2013 earnings per American Depositary Share (ADS) of ...
  15. Eli Lilly Misses but Affirms View - Analyst Blog

    October 24, 2012
    Eli Lilly & Company (LLY) reported third quarter 2012 adjusted earnings per share of 79 cents, missing the Zacks ...
  16. EC Nod for Watson's Actavis Deal - Analyst Blog

    October 09, 2012
    Watson Pharmaceuticals, Inc. (WPI) recently received the green signal from the European Commission (EC) for its ...
  17. Dr. Reddy's Laboratories Limited Among Healthcare's ...

    October 04, 2012
    Currently, the Nasdaq has been relatively flat, the S&P 500 has risen 0.4% and the Dow has moved up 0.5%. The ...
  18. Diageo Looks To Grab Market Share In India

    September 27, 2012
    Diageo announced September 25 that it was negotiating with Indian billionaire Vijay Mallya for part of his 28% stake ...
  19. Dr. Reddy's Launches Generic Amoxil - Analyst Blog

    September 21, 2012
    Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of GlaxoSmithKline's (GSK) ...
  20. Gilead and More Big Movers in Healthcare on September ...

    September 17, 2012
    The market is having a bad day so far: the Nasdaq has slipped 0.2%; the S&P 500 has declined 0.2%; and the Dow is ...
Marketplace
Trading Center